Ever Source Wealth Advisors, LLC Xenon Pharmaceuticals Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 30 shares of XENE stock, worth $1,053. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 418
92.82%
Holding current value
$1,053
Previous $16,000
93.75%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$199 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$159 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$102 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$101 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$96.2 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.19B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...